V. 論文業績一覧
V-1.

一元化登録（2009年4月以降）データ利用申請・WG研究
論文タイトル

論文業績

著者

1

小児へのさい帯血移植.

2

Pre-transplant imatinib-based
Mizuta S, Matsuo K, Yagasaki F,
therapy improves the outcome of
Yujiri T, Hatta Y, Kimura Y, Ueda
allogeneic hematopoietic stem cellY, Kanamori H, Usui N, Akiyamatransplantation for BCR-ABL-positive H, Miyazaki Y, Ohtake S, Atsuta Y,
acute lymphoblastic leukemia.
Sakamaki H, Kawa K, Morishima
Y, Ohnishi K, Naoe T, Ohno R.

加藤剛二.

Takanashi M, Tanaka H, Kohsaki
M, Nakajima K, Tadokoro K,
Nakabayashi M.

雑誌名発行
刊・ 業績番
年
号・頁
号
2009 54-7
U1

日本さい帯
血バンク
ネットワー
ク設立 10 周
年記念 そ
して明日か
ら
Leukemia 2011 25(1):41 U2
-7.

Bone
2011 46(7):10 U3Marrow
14-5.
Transplant3

A suggested total size for the cord
blood banks of Japan.

4

Successful cord blood transplantation Yagasaki H, Kato M, Ishige M,
Int J
in a 42-day-old boy with infantile
Shichino H, Chin M, Mugishima H. Hematol
Krabbe disease.

2011 93(4):56 U4
6-8.

5

Allogeneic hematopoietic stem celltransplantation for acute myeloid
leukemia with t(6;9)(p23;q34)
dramatically improves the patient
prognosis: a matched-pair analysis.

Ishiyama K, Takami A, Kanda Y,
Leukemia
Nakao S, Hidaka M, Maeda T, Naoe
T, Taniguchi S, Kawa K, Nagamura
T, Atsuta Y, Sakamaki H.

2012 26(3):46 U5
1-4.

6

Prognostic factors for acute myeloid
leukemia patients witht(6;9)(p23;q34) who underwent an
allogeneic hematopoietic stem celltransplant.

Ishiyama K, Takami A, Kanda Y,
Leukemia
Nakao S, Hidaka M, Maeda T, Naoe
T, Taniguchi S, Kawa K, Nagamura
T, Tabuchi K, Atsuta Y, Sakamaki
H.

2012 26(6):14 U6
16-9.

7

Peripheral blood as a preferable
Fuji S, Nakamura F, Hatanaka K, Biol Blood 2012 18(9):14 U7
source of stem cells for salvage
Taniguchi S, Sato M, Mori S,
Marrow
07-14.
transplantation in patients with graft Sakamaki H, Yabe H, Miyamoto T, Transplantfailure after cord blood
Kanamori H, Ueda Y, Kawa K, Katotransplantation: a retrospective
K, Suzuki R, Atsuta Y, Tamaki T,
analysis of the registry data of the
Kanda Y.
Japanese Society for Hematopoietic
Cell Transplantation.

8

Impact of graft-versus-host disease on Kanda J, Hishizawa M, Utsunomiya Bloodoutcomes after allogeneic
A, Taniguchi S, Eto T, Moriuchi Y,
hematopoietic cell transplantation for Tanosaki R, Kawano F, Miyazaki Y,
adult T-cell leukemia: a retrospective Masuda M, Nagafuji K, Hara M,
cohort study.
Takanashi M, Kai S, Atsuta Y,
Suzuki R, Kawase T, Matsuo K,
Nagamura-Inoue T, Kato S,
Sakamaki H, Morishima Y,
Okamura J, Ichinohe T, UchiyamaT.

2012 119(9):2 U8
141-8.

論文タイトル
9

Related transplantation with HLA-1
Ag mismatch in the GVH directionand HLA-8/8 allele-matchedunrelated transplantation: anationwide retrospective study.

10 Efficacy and long-term outcome oftreatment for pure red cell aplasia
after allogeneic stem celltransplantation from major ABOincompatible donors.

著者

雑誌名

Kanda J, Saji H, Fukuda T,
Blood
Kobayashi T, Miyamura K, Eto T,
Kurokawa M, Kanamori H, Mori T,
Hidaka M, Iwato K, Yoshida T,
Sakamaki H, Tanaka J, Kawa K,
Morishima Y, Suzuki R, Atsuta Y,
Kanda Y.
Hirokawa M, Fukuda T, Ohashi K,
Hidaka M, Ichinohe T, Iwato K,
Kanamori H, Murata M, Sakura T,
Imamura M, Adachi S, Suzuki R,
Morishima Y, Sakamaki H; PRCA
Collaborative Study Group.

発行
刊・ 業績番
年
号・頁
号
2012 119(10): U9
240916.

Biol Blood 2013 19(7):10 U10Marrow
26-32.
Transplant

Kurosawa S, Yakushijin K,
Bone2013 48(4):52 U11
11 Changes in incidence and causes of
non-relapse mortality after allogeneic Yamaguchi T, Atsuta Y, Nagamura- Marrow
9-36.
hematopoietic cell transplantation in Inoue T, Akiyama H, Taniguchi S, Transplantpatients with acuteMiyamura K, Takahashi S, Eto T,
leukemia/myelodysplastic syndrome: Ogawa H, Kurokawa M, Tanaka J,an analysis of the Japan Transplant Kawa K, Kato K, Suzuki R,
Outcome Registry.
Morishima Y, Sakamaki H, Fukuda
T.
12 Recent decrease in non-relapse
mortality due to GVHD and infection
after allogeneic hematopoietic celltransplantation in non-remission
acute leukemia.

Kurosawa S, Yakushijin K,
Bone2013 48(9):11 U12Yamaguchi T, Atsuta Y, Nagamura- Marrow
98-204.
Inoue T, Akiyama H, Taniguchi S, Transplant
Miyamura K, Takahashi S, Eto T,
Ogawa H, Kurokawa M, Tanaka J,
Kawa K, Kato K, Suzuki R,
Morishima Y, Sakamaki H, Fukuda
T.

Shinzato A, Tabuchi K, Atsuta Y,
Pediatr
13 PBSCT is associated with poorer
survival and increased chronic GvHD Inoue M, Inagaki J, Yabe H, Koh K, Bloodthan BMT in Japanese paediatric
Kato K, Ohta H, Kigasawa H, Kitoh Cancer
patients with acute leukaemia and an T, Ogawa A, Takahashi Y, Sasahara
HLA-matched sibling donor.
Y, Kato S, Adachi S.

2013 60(9):15 U13
13-9.

14 Allogeneic hematopoietic stem celltransplantation for intermediate
cytogenetic risk AML in first CR.

Imahashi N, Suzuki R, Fukuda T,
Bone2013 48(1):56 U14
Kakihana K, Kanamori H, Eto T,
Marrow-62.
Mori T, Kobayashi N, Iwato K,
Transplant
Sakura T, Ikegame K, Kurokawa M,
Kondo T, Iida H, Sakamaki H,
Tanaka J, Kawa K, Morishima Y,
Atsuta Y, Miyamura K.

15 Feasibility of reduced-intensity
conditioning followed by unrelated
cord blood transplantation forprimary hemophagocytic
lymphohistiocytosis: a nationwide
retrospective analysis in Japan.

Sawada A, Ohga S, Ishii E, Inoue
Int J
M, Okada K, Inagaki J, Goto H,
Hematol
Suzuki N, Koike K, Atsuta Y,
Suzuki R, Yabe H, Kawa K, Kato K,
Yasutomo K.

2013 98(2):22 U15
3-30.

血液事業

2013 35(4):70 U16
3-5.

16 移植に必要なAB型の血漿・血小板製剤 永澤雅秀の需給動向について

論文タイトル

著者

17 Association between decreasing trend Chihara D, Ito H, Matsuda T,
in the mortality of adult T-cell
Katanoda K, Shibata A, Taniguchi
leukemia/lymphoma and allogeneic
S, Utsunomiya A, Sobue T, Matsuo
hematopoietic stem cell transplants
K.
in Japan: analysis of Japanese vitalstatistics and Japan Society for
Hematopoietic Cell Transplantation(JSHCT).

雑誌名

Blood
Cancer J

18 Granulocyte colony-stimulating factor Konuma T, Ooi J, Uchida N, Ogawa Haematolo
combined regimen in cord blood
H, Ohashi K, Kanamori H, Aotsuka gica
transplantation for acute myeloid
N, Onishi Y, Yamaguchi H, Kozai Y,
leukemia: a nationwide retrospective Nagamura-Inoue T, Kato K, Suzuki
analysis in Japan.
R, Atsuta Y, Kato S, Asano S,
Takahashi S.

発行
刊・ 業績番
年
号・頁
号
2013 3:e159. U17

2014 99(12):e U18
264-8.

19 Mycophenolate mofetil use after
unrelated hematopoietic stem celltransplantation for prophylaxis andtreatment of graft-vs.-host disease in
adult patients in Japan.

Iida M, Fukuda T, Uchida N,
Clin
2014 28(9):98 U19
Murata M, Aotsuka N, Minagawa
Transplant
0-9.
K, Oohashi K, Fukushima K, Kondo
T, Eto T, Miyamoto T, Morishima Y,
Nagamura T, Atsuta Y, Suzuki R.

20 Allogeneic transplantation forprimary myelofibrosis with BM,
peripheral blood or umbilical cord
blood: an analysis of the JSHCT.

Murata M, Nishida T, Taniguchi S, Bone2014 49(3):35 U20
Ohashi K, Ogawa H, Fukuda T,
Marrow
5-60.
Mori T, Kobayashi H, Nakaseko C, Transplant
Yamagata N, Morishima Y,
Nagamura-Inoue T, Sakamaki H,
Atsuta Y, Suzuki R, Naoe T.

21 Hematopoietic stem celltransplantation for inborn errors of
metabolism: A report from the
Research Committee on
Transplantation for Inborn Errors ofMetabolism of the Japanese Ministryof Health, Labour and Welfare andthe Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.

Kato S, Yabe H, Takakura H,
Pediatr
2016 20(2):20 U21
Mugishima H, Ishige M, Tanaka A, Transplant
3-14.
Kato K, Yoshida N, Adachi S, Sakai
N, Hashii Y, Ohashi T, Sasahara Y,
Suzuki Y, Tabuchi K.

22 A phase I/II trial of intrabone marrow Kurita N, Gosho M, Yokoyama Y,
cord blood transplantation and
Kato T, Obara N, Sakatacomparison of the hematologicalYanagimoto M, Hasegawa Y,
recovery with the JapaneseUchida N, Takahashi S, Kouzai Y,
nationwide database.
Atsuta Y, Kurata M, Ichinohe T,
Chiba S.
23 Reduced intensity conditioning inallogeneic stem cell transplantation
for AML with Down syndrome.

Bone2017 52(4):57 U22Marrow
4-9.
Transplant

Muramatsu H, Sakaguchi H, Taga Pediatr
T, Tabuchi K, Adachi S, Inoue M,
Blood
Kitoh T, Suminoe A, Yabe H,
CancerAzuma E, Shioda Y, Ogawa A,
Kinoshita A, Kigasawa H, Osugi Y,
Koike K, Kawa K, Kato K, Atsuta Y,
Kudo K.

2014 61(5):92 WGP
5-7.
1-1

論文タイトル
24 Comparison of a fludarabine andmelphalan combination-based
reduced toxicity conditioning withmyeloablative conditioning byradiation and/or busulfan in acute
myeloid leukemia in Japanesechildren and adolescents.

著者
Ishida H, Adachi S, Hasegawa D,
Okamoto Y, Goto H, Inagaki J,
Inoue M, Koh K, Yabe H, Kawa K,
Kato K, Atsuta Y, Kudo K.

雑誌名Pediatr
Blood
Cancer発行
刊・ 業績番
年
号・頁
号
2015 62(5):88 WGP
3-9.
1-2

25 Comparison of Outcomes for Pediatric Ishida H, Kato M, Kudo K, Taga T, Biol Blood 2015 21(12):2 WGP
Patients With Acute Myeloid
Tomizawa D, Miyamura T, Goto H, Marrow141-7. 1-3
Leukemia in Remission andInagaki J, Koh K, Terui K, Ogawa Transplant
Undergoing Allogeneic Hematopoietic A, Kawano Y, Inoue M, Sawada A,
Cell Transplantation With
Kato K, Atsuta Y, Yamashita T,
Myeloablative Conditioning Regimens Adachi S.
Based on Either Intravenous
Busulfan or Total Body Irradiation: A
Report From the Japanese Society for
Hematopoietic Cell Transplantation.

Pediatr
Blood
Cancer

26 Role of Second Transplantation forChildren With Acute Myeloid
Leukemia Following
Posttransplantation Relapse.

Taga T, Murakami Y, Tabuchi K,
Adachi S, Tomizawa D, Kojima Y,
Kato K, Koike K, Koh K, Kajiwara
R, Hamamoto K, Yabe H, Kawa K,
Atsuta Y, Kudo K.

2016 63(4):70 WGP
1-5.
1-4

27 Allogeneic Hematopoietic Stem Cell
Transplantation for Adolescents andYoung Adults with Acute Myeloid
Leukemia.

Tomizawa D, Tanaka S, Kondo T,
Biol Blood 2017 23(9):15 WGP
Hashii Y, Arai Y, Kudo K, Taga T, Marrow
15-22. 1-5
Fukuda T, Goto H, Inagaki J, Koh Transplant
K, Ohashi K, Ozawa Y, Inoue M,
Kato K,Tanaka J, Atsuta Y, Adachi
S, Ishida H.

28 Donor lymphocyte infusion for thetreatment of relapsed acute myeloid
leukemia after allogeneic
hematopoietic stem celltransplantation: a retrospective
analysis by the Adult Acute Myeloid
Leukemia Working Group of theJapan Society for Hematopoietic Cell
Transplantation.

Takami A, Yano S, Yokoyama H,
Biol Blood 2014 20(11):1 WGP
Kuwatsuka Y, Yamaguchi T, Kanda Marrow
785-90. 2-1
Y, Morishima Y, Fukuda T,
TransplantMiyazaki Y, Nakamae H, Tanaka J,
Atsuta Y, Kanamori H.

29 Outcome of allogeneic hematopoietic
stem cell transplantation for acute
myeloid leukemia patients withcentral nervous system involvement.

Aoki J, Ishiyama K, Taniguchi S,
Fukuda T, Ohashi K, Ogawa H,
Kanamori H, Eto T, Iwato K,
Sakamaki H, Morishima Y,
Nagamura T, Atsuta Y, Takami A.

30 Efficiency of high-dose cytarabine
added to CY/TBI in cord bloodtransplantation for myeloid
malignancy.

Arai Y, Takeda J, Aoki K, Kondo T, Blood
Takahashi S, Onishi Y, Ozawa Y,
Aotsuka N, Kouzai Y, Nakamae H,
Ota S, Nakaseko C, Yamaguchi H,
Kato K, Atsuta Y, Takami A ; AML
and MDS Working Group of theJapan Society for Hematopoietic
Cell Transplantation.

Biol Blood 2014 20(12):2 WGP
Marrow
029-33. 2-2
Transplant2015 126(3):4 WGP
15-22. 2-3

論文タイトル
31 Clinical significance of high-dose
cytarabine added tocyclophosphamide/total-body
irradiation in bone marrow or
peripheral blood stem celltransplantation for myeloid
malignancy.

著者

雑誌名

Arai Y, Aoki K, Takeda J, Kondo T, J Hematol
Eto T, Ota S, Hashimoto H, Fukuda Oncol
T, Ozawa Y, Kanda Y, Kato C,
Kurokawa M, Iwato K, Onizuka M,
Ichinohe T, Atsuta Y, Takami A ;AML and MDS Working Group ofJapan Society for Hematopoietic
Cell Transplantation.

Aoki J, Kanamori H, Tanaka M,
Am J
32 Impact of age on outcomes ofallogeneic hematopoietic stem cellYamasaki S, Fukuda T, Ogawa H, Hematoltransplantation with reduced
Iwato K, Ohashi K, Okumura H,
intensity conditioning in elderly
Onizuka M, Maesako Y, Teshima T,
patients with acute myeloid leukemia. Kobayashi N, Morishima Y,
Hirokawa M, Atsuta Y, Yano S,
Takami A.

発行
刊・ 業績番
年
号・頁
号
2015 8:102. WGP
2-4

2016 91(3):30 WGP
2-7.
2-5

33 Impact of low-dose TBI on outcomesof reduced intensity conditioning
allogeneic hematopoietic stem celltransplantation for AML.

Aoki J, Seo S, Kanamori H, Tanaka Bone2016 51(4):60 WGP
M, Fukuda T, Onizuka M,
Marrow
4-6.
2-6
Kobayashi N, Kondo T, Sawa M,
Transplant
Uchida N, Iwato K, Icihnohe T,
Atsuta Y, Yano S, Takami A.

34 Comparable outcomes between
autologous and allogeneic transplant
for adult acute myeloid leukemia infirst CR.

Mizutani M, Hara M, Fujita H, Aoki Bone2016 51(5):64 WGP
J, Kanamori H, Ohashi K, Usuki K, Marrow
5-53.
2-7
Fukuda T, Chou T, Tanaka J,
Transplant
Atsuta Y, Takami A.

35 Outcomes of allogeneic hematopoietic Mori J, Ishiyama K, Yamaguchi T, Ann
cell transplantation in patients with Tanaka J, Uchida N, Kobayashi T, Hematolbiphenotypic acute leukemia.
Fukuda T, Kanamori H, Miyamura
K, Takahashi S, Eto T, Hirokawa
M, Mori S, Nagamura T, Atsuta Y,
Takami A.
Ishiyama K, Yamaguchi T, Eto T,
36 Acute megakaryoblastic leukemia,
unlike acute erythroid leukemia,
Ohashi K, Uchida N, Kanamori H,
predicts an unfavorable outcome after Fukuda T, Miyamura K, Inoue Y,
allogeneic HSCT.
Taguchi J, Mori T, Iwato K,
Morishima Y, Nagamura-Inoue T,
Atsuta Y, Sakamaki H, Takami A.

Leuk ResAnn
37 Role of reduced-intensity conditioning Yamasaki S, Hirakawa A, Aoki J,
allogeneic hematopoietic cell
Uchida N, Fukuda T, Ogawa H,
Hematoltransplantation in older patients with Ohashi K, Kondo T, Eto T,
de novo acute myeloid leukemia.
Kanamori H, Okumura H, Iwato K,
Ichinohe T, Kanda J, Onizuka M,
Kuwatsuka Y, Yanada M, Atsuta Y,
Takami A, Yano S.
38 Reduced-intensity conditioning
allogeneic hematopoietic celltransplantation for younger patientswith acute myeloid leukemia: aregistry-based study.

2016 95(2):29 WGP
5-300. 2-8

2016 47:4753.

WGP
2-9

2017 96(2):28 WGP
9-97.
2-10

Yanada M, Kurosawa S, Kobayashi Bone2017 52(6):81 WGPT, Ozawa Y, Kanamori H,
Marrow
8-24.
2-11
Kobayashi N, Sawa M, Nakamae H, Transplant
Uchida N, Hashimoto H, Fukuda T,
Hirokawa M, Atsuta Y, Yano S.

論文タイトル
39 Allogeneic Hematopoietic Cell
Transplantation for Leukemic
Transformation Preceded byPhiladelphia Chromosome-Negative
Myeloproliferative Neoplasms: A
Nationwide Survey by the Adult
Acute Myeloid Leukemia Working
Group of the Japan Society for
Hematopoietic Cell Transplantation.

著者

雑誌名

Takagi S, Masuoka K, Uchida N,
Kurokawa M, Nakamae H, ImadaK, Iwato K, Ichinohe T, Atsuta Y,
Takami A, Yano S.

Biol Blood
Marrow
Transplant

40 Outcome of allogeneic hematopoietic Konuma T, Kondo T, Yamashita T, Annstem cell transplantation in adult
Uchida N, Fukuda T, Ozawa Y,
Hematolpatients with acute myeloid leukemia Ohashi K, Ogawa H, Kato C,
harboring trisomy 8.
Takahashi S, Kanamori H, Eto T,
Nakaseko C, Kohno A, Ichinohe T,
Atsuta Y, Takami A, Yano S; Adult
Acute Myeloid Leukemia Working
Group of the Japan Society for
Hematopoietic Cell Transplantation(JSHCT).

発行
刊・ 業績番
年
号・頁
号
2016 22(12):2 WGP
208-13. 2-12

2017 96(3):46 WGP
9-78.
2-13

41 Autologous hematopoietic celltransplantation for acutepromyelocytic leukemia in second
complete remission: outcomes before
and after the introduction of arsenic
trioxide.

Yanada M, Yano S, Kanamori H,
Leuk2017 58(5):10 WGP
Gotoh M, Emi N, Watakabe K,
Lymphoma
61-7.
2-14
Kurokawa M, Nishikawa A, Mori T,
Tomita N, Murata M, Hashimoto H,
Henzan H, Kanda Y, Sawa M,
Kohno A, Atsuta Y, Ichinohe T,
Takami A.

42 Outcomes of Allogeneic
Hematopoietic Cell Transplantationin Acute Myeloid Leukemia Patientswith Abnormalities of the Short Arm
of Chromosome 17.

Mori J, Yanada M, Uchida N,
Biol Blood 2017 23(8):13 WGP
Fukuda T, Sakura T, Hidaka M,
Marrow
98-404. 2-15
Watakabe-Inamoto K, Kanamori H, TransplantOgawa H, Ichinohe T, Tanaka J,
Atsuta Y, Yano S.

Yanada M, Mori J, Aoki J, Harada
43 Effect of cytogenetic risk status on
outcomes for patients with acuteK, Mizuno S, Uchida N, Kurosawa
myeloid leukemia undergoing various S, Toya T, Kanamori H, Ozawa Y,
types of allogeneic hematopoietic cell Ogawa H, Henzan H, Iwato K,
transplantation: an analysis of 7812 Sakura T, Ota S, Fukuda T,
patients.
Ichinohe T, Atsuta Y, Yano S.

Leuk2018 59(3):60 WGP
Lymphoma
1-9.
2-16

44 Outcomes after allogeneic
hematopoietic stem celltransplantation in patients withacute myeloid leukemia harboringt(7;11)(p15;p15).

Harada K, Doki N, Aoki J, Mori J, Haematolo
Machida S, Masuko M, Uchida N,
gica
Najima Y, Fukuda T, Kanamori H,
Ogawa H, Ota S, Ogawa K,
Takahashi S, Kasai M, Maeda A,
Nagafuji K, Kawakita T, Ichinohe T,
Atsuta Y.

45 Comparison of Autologous andUnrelated Transplants for
Cytogenetically Normal Acute
Myelogenous Leukemia.

Mizutani M, Takami A, Hara M,
Mizuno S, Yanada M, Chou T,
Uchiyama H, Ohashi K, Miyamoto
T, Ozawa Y, Imataki O, Kobayashi
N, Uchida N, Kanamori H,
Kamimura T, Eto T, Onizuka M,
Tanaka J, Atsuta Y, Yano S.

2018 103(2):e WGP
69-72. 2-17

Biol Blood 2017 23(9):14 WGP
Marrow
47-54. 2-18
Transplant

論文タイトル

著者

46 Second allogeneic hematopoietic SCT Kato M, Horikoshi Y, Okamoto Y,
for relapsed ALL in children.
Takahashi Y, Hasegawa D, Koh K,
Takita J, Inoue M, Kigasawa H,
Ogawa A, Sasahara Y, Kawa K,
Yabe H, Sakamaki H, Suzuki R,
Kato K.

雑誌名

Bone
Marrow
Transplant

発行
刊・ 業績番
年
号・頁
号
2012 47(10):1 WGP
307-11. 3-1

47 Comparison of intravenous with oral
busulfan in allogeneic hematopoietic
stem cell transplantation withmyeloablative conditioning regimens
for pediatric acute leukemia.

Kato M, Takahashi Y, Tomizawa D, Biol Blood 2013 19(12):1 WGP
Okamoto Y, Inagaki J, Koh K,
Marrow
690-4. 3-2
Ogawa A, Okada K, Cho Y, Takita Transplant
J, Goto H, Sakamaki H, Yabe H,
Kawa K, Suzuki R, Kudo K, Kato K.

48 Comparison of transplantation with
reduced and myeloablative
conditioning for children with acutelymphoblastic leukemia.

Kato K, Kato M, Hasegawa D,
Blood
Kawasaki H, Ishida H, Okamoto Y,
Koh K, Inoue M, Inagaki J, Kato K,
Sakamaki H, Yabe H, Kawa K,
Suzuki R, Atsuta Y.

49 Hematopoietic stem celltransplantation for patients withacute lymphoblastic leukemia and
Down syndrome.

Goto H, Kaneko T, Shioda Y,
Kajiwara M, Sakashita K, Kitoh T,
Hayakawa A, Miki M, Kato K,
Ogawa A, Hashii Y, Inukai T, Kato
C, Sakamaki H, Yabe H, Suzuki R,
Kato K.

Kato M, Hasegawa D, Koh K, Kato
50 Allogeneic haematopoietic stem celltransplantation for infant acute
K, Takita J, Inagaki J, Yabe H,
lymphoblastic leukaemia with
Goto H, Adachi S, Hayakawa A,
KMT2A (MLL) rearrangements: aTakeshita Y, Sawada A, Atsuta Y,
retrospective study from the
Kato K.
paediatric acute lymphoblastic
leukaemia working group of theJapan Society for Haematopoietic Cell
Transplantation.

2015 125(8):1 WGP
352-4. 3-3

Pediatr
Blood
Cancer2015 62(1):14 WGP
8-52.
3-4

Br J
Haematol

2015 168(4):5 WGP
64-70. 3-5

Kato M, Ishida H, Koh K, Inagaki J, Pediatr
51 Comparison of chemotherapeutic
agents as a myeloablative
Kato K, Goto H, Kaneko T, Cho Y, Bloodconditioning with total body
Hashii Y, Kurosawa H, Takita J,
Cancerirradiation for pediatric acuteHamamoto K, Inoue M, Sawada A,
lymphoblastic leukemia: A study from Suzuki R, Kato K.
the pediatric ALL working group of
the Japan Society for Hematopoietic
Cell Transplantation.

2015 62(10):1 WGP
844-50. 3-6

Bone2013 48(12):1 WGP
52 Reduced-intensity allogeneic stem cell Kanamori H, Mizuta S, Kako S,
transplantation for patients aged 50 Kato H, Nishiwaki S, Imai K,
Marrow
513-8. 4-1
years or older with B-cell ALL in
Shigematsu A, Nakamae H, Tanaka Transplant
remission: a retrospective study by
M, Ikegame K, Yujiri T, Fukuda T,
the Adult ALL Working Group of the Minagawa K, Eto T, NagamuraJapan Society for Hematopoietic Cell Inoue T, Morishima Y, Suzuki R,
Transplantation.
Sakamaki H, Tanaka J.

論文タイトル

著者

雑誌名

発行
刊・ 業績番
年
号・頁
号
2013 24(6):15 WGP
94-602. 4-2

53 Impact of a donor source on adult
Philadelphia chromosome-negative
acute lymphoblastic leukemia: aretrospective analysis from the Adult
Acute Lymphoblastic Leukemia
Working Group of the Japan Societyfor Hematopoietic Cell
Transplantation.

Nishiwaki S, Miyamura K, Ohashi Ann Oncol
K, Kurokawa M, Taniguchi S,
Fukuda T, Ikegame K, Takahashi S,
Mori T, Imai K, Iida H, Hidaka M,
Sakamaki H, Morishima Y, Kato K,
Suzuki R, Tanaka J; Adult Acute
Lymphoblastic Leukemia Working
Group of the Japan Society for
Hematopoietic Cell
Transplantation.

54 Reduced-intensity vs myeloablative
conditioning allogeneic hematopoietic
SCT for patients aged over 45 years
with ALL in remission: a study fromthe Adult ALL Working Group of theJapan Society for Hematopoietic Cell
Transplantation (JSHCT).

Tanaka J, Kanamori H, Nishiwaki
S, Ohashi K, Taniguchi S, Eto T,
Nakamae H, Minagawa K,
Miyamura K, Sakamaki H,
Morishima Y, Kato K, Suzuki R,
Nishimoto N, Oba K, Masauzi N.

55 Analysis of outcomes following
autologous stem-cell transplantationin adult patients with Philadelphia
chromosome-negative acutelymphoblastic leukemia during thefirst complete remission.

Kato H, Kawase T, Kako S, Mizuta Haematolo
S, Kurokawa M, Mori T, Ohashi K, gica
Iwato K, Miyamura K, Hidaka M,
Sakamaki H, Suzuki R, Morishima
Y, Tanaka J.; Adult Acute
Lymphoblastic Leukemia Working
Group of Japan Society for
Hematopoietic Cell Transplantation(JSHCT).

2014 99(11):e WGP
228-30. 4-4

56 Pretransplant administration of
imatinib for allo-HSCT in patientswith BCR-ABL-positive acutelymphoblastic leukemia.

Mizuta S, Matsuo K, Nishiwaki S, Blood
Imai K, Kanamori H, Ohashi K,
Fukuda T, Onishi Y, Miyamura K,Takahashi S, Onizuka M, Atsuta Y,
Suzuki R, Morishima Y, Kato K,
Sakamaki H, Tanaka J.

2014 123(15): WGP
23254-532.

Bone2013 48(11):1 WGPMarrow
389-94. 4-3
TransplantBone
2016 51(1):43 WGP
57 Impact of MRD and TKI on allogeneic Nishiwaki S, Imai K, Mizuta S,
hematopoietic cell transplantation for Kanamori H, Ohashi K, Fukuda T, Marrow-50.
4-6
Ph+ALL: a study from the adult ALL Onishi Y, Takahashi S, Uchida N,
Transplant
WG of the JSHCT.
Eto T, Nakamae H, Yujiri T, Mori S,
Nagamura-Inoue T, Suzuki R,
Atsuta Y, Tanaka J.
58 Comparison of Cyclophosphamide
Combined with Total Body
Irradiation, Oral Busulfan, orIntravenous Busulfan for Allogeneic
Hematopoietic Cell Transplantationin Adults with Acute Lymphoblastic
Leukemia.

Mitsuhashi K, Kako S, Shigematsu Biol Blood 2016 22(12):2 WGP
A, Atsuta Y, Doki N, Fukuda T,
Marrow
1944-7
Kanamori H, Onizuka M,
Transplant
200.
Takahashi S, Ozawa Y, Kurokawa
M, Inoue Y, Nagamura-Inoue T,
Morishima Y, Mizuta S, Tanaka J;
Adult Acute Lymphoblastic
Leukemia Working Group of theJapan Society for Hematopoietic
Cell Transplantation.

59 High-dose cytarabine added to
CY/TBI improves the prognosis ofcord blood transplantation for acutelymphoblastic leukemia in adults: aretrospective cohort study.

Arai Y, Kondo T, Shigematsu A,
Bone2016 51(12):1 WGP
Tanaka J, Takahashi S, Kobayashi Marrow
636-9. 4-8
T, Uchida N, Onishi Y, Ishikawa J, Transplant
Kanamori H, Sawa M, Yokota A,
Kouzai Y, Takanashi M, Ichinohe T,
Atsuta Y, Mizuta S.

論文タイトル

著者

雑誌名

発行
刊・ 業績番
年
号・頁
号
2017 178(1):1 WGP
06-11. 4-9

60 Increased non-relapse mortality due
to high-dose cytarabine plus CY/TBI
in BMT/PBSCT for acutelymphoblastic leukaemia in adults.

Arai Y, Kondo T, Shigematsu A,
Br J
Tanaka J, Ohashi K, Fukuda T,
Haematol
Kawakita T, Mori T, Hoshino T,
Onizuka M, Ozawa Y, Yoshida S,
Ueda Y, Mizuno I, Atsuta Y, Mizuta
S; Japan Society for Haematopoietic
Cell Transplantation.

61 Allogeneic stem cell transplantation
for adult patients with acutelymphoblastic leukemia who had
central nervous system involvement:a study from the Adult ALL Working
Group of the Japan Society for
Hematopoietic Cell Transplantation.

Shigematsu A, Kako S, Mitsuhashi Int J
K, Iwato K, Uchida N, Kanda Y,
Hematol
Fukuda T, Sawa M, Senoo Y,
Ogawa H, Miyamura K, Takada S,
Nagamura-Inoue T, Morishima Y,
Ichinohe T, Atsuta Y, Mizuta S,
Tanaka J.

2017 105(6):8 WGP
05-11. 4-10

62 Improved prognosis with additional
medium-dose VP16 to CY/TBI inallogeneic transplantation for highrisk ALL in adults.

Arai Y, Kondo T, Shigematsu A,
Am J
Tanaka J, Ohashi K, Fukuda T,
Hematol
Hidaka M, Kobayashi N, Iwato K,
Sakura T, Onizuka M, Ozawa Y,
Eto T, Kurokawa M, Kahata K,
Uchida N, Atsuta Y, Mizuta S, Kako
S.

2018 93(1):47 WGP
-57.
4-11

63 Effect of graft sources on allogeneic
hematopoietic stem celltransplantation outcome in adults
with chronic myeloid leukemia in theera of tyrosine kinase inhibitors: aJapanese Society of Hematopoietic
Cell Transplantation retrospective
analysis.

Ohashi K, Nagamura-Inoue T,
Int J
Nagamura F, Tojo A, Miyamura K, HematolMori T, Kurokawa M, Taniguchi S,
Ishikawa J, Morishima Y, Atsuta Y,
Sakamaki H.

2014 100(3):2 WGP
96-306. 6-1

64 Clinical impact of pretransplant use
of multiple tyrosine kinase inhibitorson the outcome of allogeneic
hematopoietic stem celltransplantation for chronic
myelogenous leukemia.

Kondo T, Nagamura-Inoue T, Tojo Am J
A, Nagamura F, Uchida N,
Hematol
Nakamae H, Fukuda T, Mori T,
Yano S, Kurokawa M, Ueno H,
Kanamori H, Hashimoto H,
Onizuka M, Takanashi M, Ichinohe
T, Atsuta Y, Ohashi K.

2017 92(9):90 WGP
2-8.
6-2

65 Salvage allogeneic stem celltransplantation in patients withpediatric myelodysplastic syndrome
and myeloproliferative neoplasms.

Kato M, Yoshida N, Inagaki J,
PediatrMaeba H, Kudo K, Cho Y,
Blood
Kurosawa H, Okimoto Y, Tauchi H, Cancer
Yabe H, Sawada A, Kato K, Atsuta
Y, Watanabe K.

2014 61(10):1 WGP
860-6. 7-1

66 Allogeneic haematopoietic celltransplantation with reducedintensity conditioning for elderly
patients with advanced
myelodysplastic syndromes: anationwide study.

Aoki K, Ishikawa T, Ishiyama K,
Br J
Aoki J, Itonaga H, Fukuda T,
Haematol
Kakihana K, Uchida N, Ueda Y, Eto
T, Mori T, Kondo T, Iwato K,
Morishima Y, Tanaka J, Atsuta Y,
Miyazaki Y; Adult Myelodysplastic
Syndromes Working Group of theJapan Society for Hematopoietic
Cell Transplantation (JSHCT).

2015 168(3):4 WGP
63-6.
8-1

論文タイトル

著者

雑誌名

発行
刊・ 業績番
年
号・頁
号
2015 21(9):16 WGP
32-40. 8-2

67 Effect of Granulocyte ColonyStimulating Factor-Combined
Conditioning in Cord Blood
Transplantation for Myelodysplastic
Syndrome and Secondary Acute
Myeloid Leukemia: A Retrospective
Study in Japan.

Konuma T, Takahashi S, Uchida N, Biol Blood
Kuwatsuka Y, Yamasaki S, Aoki J, Marrow
Onishi Y, Aotsuka N, Ohashi K,
TransplantMori T, Masuko M, Nakamae H,
Miyamura K, Kato K, Atsuta Y,
Kato S, Asano S, Takami A,
Miyazaki Y; Adult Myelodysplastic
Syndrome and Adult Acute Myeloid
Leukemia Working Group of theJapan Society for Hematopoietic
Cell Transplantation.

68 Impacts of graft-versus-host diseaseon outcomes after allogeneic
hematopoietic stem celltransplantation for chronic
myelomonocytic leukemia: A
nationwide retrospective study.

Itonaga H, Iwanaga M, Aoki K, Aoki Leuk Res
J, Ishiyama K, Ishikawa T, Sakura
T, Fukuda T, Najima Y, Yujiri T,
Mori T, Kurokawa M, Nawa Y,
Uchida N, Morishita Y, Hashimoto
H, Eto T, Hirokawa M, Morishima
Y, Nagamura-Inoue T, Atsuta Y,
Miyazaki Y.

69 Outcomes of Allogeneic
Hematopoietic Stem Cell
Transplantation in Adult Patientswith Myelodysplastic Syndrome
Harboring Trisomy 8.

Konuma T, Miyazaki Y, Uchida N, Biol Blood 2017 23(1):75 WGP
Ohashi K, Kondo T, Nakamae H,
Marrow-80.
8-4Takahashi S, Mori T, Ozawa Y,
Transplant
Kato C, Iwato K, Fukuda T,
Ichinohe T, Atsuta Y, Ishiyama K;
Adult Myelodysplastic Syndrome
Working Group of the Japan Societyfor Hematopoietic Cell
Transplantation.

2016 41:4855.

WGP
8-3

70 Prognostic Impact of Donor Source on Itonaga H, Aoki K, Aoki J, Ishikawa Biol Blood
Allogeneic Hematopoietic Stem Cell T, Ishiyama K, Uchida N, Sakura T, Marrow
Transplantation Outcomes in Adults Ohashi K, Kurokawa M, Ozawa Y, Transplantwith Chronic Myelomonocytic
Matsuoka KI, Nakamura Y, Kimura
Leukemia: A Nationwide
F, Iwato K, Nawa Y, Hirokawa M,
Retrospective Analysis in Japan.
Kato K, Ichinohe T, Atsuta Y,
Miyazaki Y.

in press WGP
8-5

71 Stem cell transplantation for
paediatric patients with nonanaplastic peripheral T-cell
lymphoma in Japan.

Kobayashi R, Fujita N, Mitsui T,
Br J
Iwasaki F, Suzumiya J, Kuroda H, Haematol
Nishimura R, Sasahara Y,
Takeshita Y, Kato K, Okumura H,
Sakamaki H, Yabe H, Kawa K, Kato
K, Suzuki R.

2012 159(1):8 WGP
8-93.
9-1

72 Haematopoietic stem celltransplantation for relapsed or
refractory anaplastic large cell
lymphoma: a study of children andadolescents in Japan.

Fukano R, Mori T, Kobayashi R,
Mitsui T, Fujita N, Iwasaki F,
Suzumiya J, Chin M, Goto H,
Takahashi Y, Hara J, Park YD,
Inoue M, Koga Y, Inagaki J,
Sakamaki H, Adachi S, Kawa K,
Kato K, Suzuki R.

Br J
Haematol

2015 168(4):5 WGP
57-63. 9-2

論文タイトル

著者

雑誌名

Int J
73 Outcome differences between children Kobayashi R, Mitsui T, Fujita N,
and adolescents and young adults
Osumi T, Aoki T, Aoki K, Suzuki R, Hematolwith non-Hodgkin lymphoma
Fukuda T, Miyamoto T, Kato K,
following stem cell transplantation.
Nakamae H, Goto H, Eto T, Inoue
M, Mori T, Terui K, Onizuka M,
Koh K, Koga Y, Ichinohe T, Sawada
A, Atsuta Y, Suzumiya J.
Chihara D, Izutsu K, Kondo E,
74 High-dose chemotherapy withautologous stem cell transplantation Sakai R, Mizuta S, Yokoyama K,
for elderly patients with
Kaneko H, Kato K, Hasegawa Y,
relapsed/refractory diffuse large B cell Chou T, Sugahara H, Henzan H,
lymphoma: a nationwide retrospective Sakamaki H, Suzuki R, Suzumiya
study.
J.

発行
刊・ 業績番
年
号・頁
号
2017 105(3):3 WGP
69-76. 9-3

Biol Blood 2014 20(5):68 WGPMarrow
4-9.
10-1
Transplant

75 The role of hematopoietic stem celltransplantation for relapsed andrefractory Hodgkin lymphoma.

Kako S, Izutsu K, Kato K, Kim SW, Am J
Mori T, Fukuda T, Kobayashi N,
HematolTaji H, Hashimoto H, Kondo T,
Sakamaki H, Morishima Y, Kato K,
Suzuki R, Suzumiya J; Adult
Lymphoma Working Group of theJapanese Society for Hematopoietic
Cell Transplantation.

2015 90(2):13 WGP
2-8.
10-2

76 Long-term survival following
autologous and allogeneic stem celltransplantation for blastic
plasmacytoid dendritic cell neoplasm.

Aoki T, Suzuki R, Kuwatsuka Y,
Blood
Kako S, Fujimoto K, Taguchi J,
Kondo T, Ohata K, Ito T, Kamoda Y,
Fukuda T, Ichinohe T, Takeuchi K,
Izutsu K, Suzumiya J.

2015 125(23): WGP
355910-3
62.

77 Long-term outcome of childhoodaplastic anemia patients who
underwent allogeneic hematopoietic
SCT from an HLA-matched sibling
donor in Japan.

Kikuchi A, Yabe H, Kato K, Koh K, Bone2013 48(5):65 WGP
Inagaki J, Sasahara Y, Suzuki R,
Marrow
7-60.
11-1
Yoshida N, Kudo K, Kobayashi
Transplant
R,Tabuchi K, Kawa K, Kojima S.

78 First-line treatment for severe
aplastic anemia in children: bonemarrow transplantation from amatched family donor versus
immunosuppressive therapy.

Yoshida N, Kobayashi R, Yabe H,
Kosaka Y, Yagasaki H, Watanabe
K, Kudo K, Morimoto A, Ohga S,
Muramatsu H, Takahashi Y, Kato
K, Suzuki R, Ohara A, Kojima S.

Haematolo 2014 99(12):1 WGP
gica
784-91. 11-2

79 Bloodstream infection after stem celltransplantation in children with
idiopathic aplastic anemia.

Kobayashi R, Yabe H, Kikuchi A,
Kudo K, Yoshida N, Watanabe K,
Muramatsu H, Takahashi Y, Inoue
M, Koh K, Inagaki J, Okamoto Y,
Sakamaki H, Kawa K, Kato K,
Suzuki R, Kojima S.

Biol Blood 2014 20(8):11 WGPMarrow
45-9.
11-3
Transplant2015 50(10):1 WGP
80 Second allogeneic hematopoietic stem Kudo K, Muramatsu H, Yoshida N, Bonecell transplantation in children with Kobayashi R, Yabe H, Tabuchi K,
Marrow
312-5. 11-4
severe aplastic anemia.
Kato K, Koh K, Takahashi Y,
Transplant
Hashii Y, Kawano Y, Inoue M, Cho
Y, Sakamaki H, Kawa K, Kato K,
Suzuki R, Kojima S.

論文タイトル

著者

雑誌名

81 Unrelated cord blood transplantationin aplastic anemia: is antithymocyte
globulin indispensable forconditioning?

Kudo K, Muramatsu H, Narita A,
Bone
Yoshida N, Kobayashi R, Yabe H,
Marrow
Endo M, Inoue M, Hara J, Kounami Transplant
S, Inagaki J, Hashii Y, Kato K,
Tabuchi K, Kojima S.

82 Impact of cyclophosphamide dose of
conditioning on the outcome ofallogeneic hematopoietic stem celltransplantation for aplastic anemia
from human leukocyte antigenidentical sibling.

Mori T, Koh H, Onishi Y, Kako S,
Int J
Onizuka M, Kanamori H, Ozawa Y, Hematol
Kato C, Iida H, Suzuki R, Ichinohe
T, Kanda Y, Maeda T, Nakao S,
Yamazaki H.

83 Outcome of Second Transplantation
Using Umbilical Cord Blood for Graft
Failure after Allogeneic
Hematopoietic Stem Cell
Transplantation for Aplastic Anemia.

Onishi Y, Mori T, Kako S, Koh H,
Uchida N, Kondo T, Kobayashi T,
Yabe H, Miyamoto T, Kato K,
Suzuki R, Nakao S, Yamazaki H;
Adult Aplastic Anemia Working
Group of the Japan Society for
Hematopoietic Cell
Transplantation.

2016 103(4):4 WGP
61-8.
12-1

Biol Blood 2017 23(12):2 WGP
Marrow
137-42. 12-2
Transplant

Ishida T, Hishizawa M, Kato K,
Blood
84 Allogeneic hematopoietic stem celltransplantation for adult T-cell
Tanosaki R, Fukuda T, Taniguchi S,
leukemia-lymphoma with special
Eto T, Takatsuka Y, Miyazaki Y,
emphasis on preconditioning regimen: Moriuchi Y, Hidaka M, Akashi K,
a nationwide retrospective study.
Uike N, Sakamaki H, Morishima Y,
Kato K, Suzuki R, Nishiyama T,
Utsunomiya A.
85 Impact of graft-versus-host disease on Ishida T, Hishizawa M, Kato K,
allogeneic hematopoietic cell
Tanosaki R, Fukuda T, Takatsuka
transplantation for adult T cellY, Eto T, Miyazaki Y, Hidaka M,
leukemia-lymphoma focusing on
Uike N, Miyamoto T, Tsudo M,
preconditioning regimens: nationwide Sakamaki H, Morishima Y, Suzuki
retrospective study.
R, Utsunomiya A.

発行
刊・ 業績番
年
号・頁
号
2017 52(12):1 WGP
659-61. 11-5

2012 120(8):1 WGP
734-41. 13-1

Biol Blood 2013 19(12):1 WGPMarrow
731-9. 13-2
Transplant

86 Treatment of patients with adult T
cell leukemia/lymphoma with cord
blood transplantation: a Japanesenationwide retrospective survey.

Kato K, Choi I, Wake A, Uike N,
Biol Blood 2014 20(12):1 WGP
Taniguchi S, Moriuchi Y, Miyazaki Marrow
968-74. 13-3
Y, Nakamae H, Oku E, Murata M, Transplant
Eto T, Akashi K, Sakamaki H, Kato
K, Suzuki R, Yamanaka T,
Utsunomiya A.

87 Early application of related SCT
might improve clinical outcome inadult T-cell leukemia/lymphoma.

Fuji S, Fujiwara H, Nakano N,
Bone2016 51(2):20 WGP
Wake A, Inoue Y, Fukuda T,
Marrow
5-11.
13-4
Hidaka M, Moriuchi Y, Miyamoto T, Transplant
Uike N, Taguchi J, Eto T, Tomoyose
T, Kondo T, Yamanoha A, Ichinohe
T, Atsuta Y, Utsunomiya A; ATL
Working Group of the Japan Societyfor Hematopoietic Cell
Transplantation.

論文タイトル

著者

雑誌名

発行
刊・ 業績番
年
号・頁
号
2017 52(3):48 WGP
4-8.
13-5

88 Dismal outcome of allogeneic
hematopoietic stem celltransplantation for relapsed adult Tcell leukemia/lymphoma, a Japanesenation-wide study.

Fujiwara H, Fuji S, Wake A, Kato
BoneK, Takatsuka Y, Fukuda T, Taguchi Marrow
J, Uchida N, Miyamoto T, Hidaka
Transplant
M, Miyazaki Y, Tomoyose T,
Onizuka M, Takanashi M, Ichinohe
T, Atsuta Y, Utsunomiya A; ATL
Working Group of the Japan Societyfor Hematopoietic Cell
Transplantation.

89 Risk Assessment in Adult T Cell
Leukemia/Lymphoma Treated with
Allogeneic Hematopoietic Stem Cell
Transplantation.

Yoshimitsu M, Tanosaki R, Kato K, Biol Blood
Ishida T, Choi I, Takatsuka Y,
Marrow
Fukuda T, Eto T, Hidaka M, Uchida TransplantN, Miyamoto T, Nakashima Y,
Moriuchi Y, Nagafuji K, Miyazaki
Y, Ichinohe T, Takanashi M, Atsuta
Y, Utsunomiya A; ATL Working
Group of the Japan Society for
Hematopoietic Cell
Transplantation.

in press WGP
13-6

Cancer Sci

2015 106(2):1 WGP
79-85. 14-1

90 Changing trends in prognostic factors Takamatsu H, Honda S, Miyamoto
for patients with multiple myeloma
T, Yokoyama K, Hagiwara S, Ito T,
after autologous stem cell
Tomita N, Iida S, Iwasaki T,transplantation during the
Sakamaki H, Suzuki R, Sunami K.
immunomodulator drug/proteasome
inhibitor era.
91 Cord Blood Transplantation for
Multiple Myeloma:A Study from theMultiple Myeloma Working Group of
the Japan Society for Hematopoietic
Cell Transplantation.

Kawamura K, Takamatsu H, Ikeda Biol Blood 2015 21(7):12 WGPT, Komatsu T, Aotsuka N, Amano I, Marrow
91-8.
14-2
Yamamoto G, Watanabe K, Ohno Y, Transplant
Matsue K, Kouzai Y, Tsukada N,
Ishiyama K, Anzai N, Kato K,
Suzuki R, Sunami K, Kanda Y.

Kawamura K, Ikeda T, Hagiwara S, Leuk2016 57(9):20 WGP
92 Tandem autologous versus
autologous/allogeneic transplantation Mori T, Shinagawa A, Nishiwaki K, Lymphoma
77-83. 14-3
for multiple myeloma: propensity
Ohashi K, Kubonishi S, Fukuda T,
score analysis.
Ito T, Tomita N, Ichinohe T, Kato K,
Morishima Y, Atsuta Y, Sunami K,
Kanda Y.
93 Comparison of second transplantation Umeda K, Adachi S, Tanaka S, Miki Pediatr
and donor lymphocyte infusion for
M, Okada K, Hashii Y, Inoue M,
Blood
donor mixed chimerism after
Cho Y, Koh K, Goto H, Kajiwara R, Cancer
allogeneic stem cell transplantation
Hyakuna N, Kato K, Morio T, Yabe
for nonmalignant diseases.
H; Inherited Disease Working
Group of the Japan Society for
Hematopoietic Cell
Transplantation.
94 Allogeneic Hematopoietic Stem Cell
Transplantation for Leukocyte
Adhesion Deficiency.

Horikoshi Y, Umeda K, Imai K,
Yabe H, Sasahara Y, Watanabe K,
Ozawa Y, Hashii Y, Kurosawa H,
Nonoyama S, Morio T.

J Pediatr
Hematol
Oncol

2016 63(12):2 WGP
221-9. 16-1

in press WGP
16-2

論文タイトル

著者

雑誌名

Kanda Y, Kanda J, Atsuta Y, Maeda Br J
95 Impact of a single human leucocyte
antigen (HLA) allele mismatch on the Y, Ichinohe T, Ohashi K, Fukuda T, Haematol
outcome of unrelated bone marrow
Miyamura K, Iida H, Mori T, Iwato
transplantation over two time
K, Eto T, Kawa K, Morita S,
periods. A retrospective analysis ofMorishima Y.
3003 patients from the HLA Working
Group of the Japan Society for Bloodand Marrow Transplantation.

発行
刊・ 業績番
年
号・頁
号
2013 161(4):5 WGP
66-77. 17-1

96 Effects of KIR ligand incompatibility
on clinical outcomes of umbilical cord
blood transplantation without ATG
for acute leukemia in complete
remission.

Tanaka J, Morishima Y, Takahashi BloodY, Yabe T, Oba K, Takahashi S,
Cancer J
Taniguchi S, Ogawa H, Onishi Y,
Miyamura K, Kanamori H, Aotsuka
N, Kato K, Kato S, Atsuta Y, Kanda
Y.

2013 3:e164. WGP
17-2

97 Different effects of HLA disparity ontransplant outcomes after single-unit
cord blood transplantation between
pediatric and adult patients withleukemia.

Atsuta Y, Kanda J, Takanashi M,
Haematolo
Morishima Y, Taniguchi S,
gica
Takahashi S, Ogawa H, Ohashi K,
Ohno Y, Onishi Y, Aotsuka N,
Nagamura-Inoue T, Kato K, Kanda
Y; HLA Working Group of theJapan Society for Hematopoietic
Cell Transplantation.

2013 98(5):81 WGP
4-22.
17-3

98 Impact of the direction of HLA
mismatch on transplantation
outcomes in single unrelated cord
blood transplantation.

Kanda J, Atsuta Y, Wake A,
Biol Blood 2013 19(2):24 WGP
Ichinohe T, Takanashi M,
Marrow
7-54.
17-4
Morishima Y, Taniguchi S,
Transplant
Takahashi S, Ogawa H, Ohashi K,
Ohno Y, Aotsuka N, Onishi Y, Kato
K, Nagamura-Inoue T, Kanda Y;
HLA Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.

99 Changes in the clinical impact ofhigh-risk human leukocyte antigen
allele mismatch combinations on theoutcome of unrelated bone marrowtransplantation.

Kanda Y, Kanda J, Atsuta Y, Fuji S, Biol Blood 2014 20(4):52 WGP
Maeda Y, Ichinohe T, Takanashi M, Marrow
6-35.
17-5
Ohashi K, Fukuda T, Miyamura K, TransplantMori T, Sao H, Kobayashi N, Iwato
K, Sawada A, Mori S; HLA working
group of the Japan Society for
Hematopoietic Cell
Transplantation.

100 Decision analysis for donor selection Kanda J, Fuji S, Kato S, Takami A, Bloodin stem cell transplantation-HLA-8/8 Tanaka J, Miyamura K, Ohashi K, Cancer J
allele-matched unrelated donor vs
Fukuda T, Ozawa Y, Kanamori H,
HLA-1 AG mismatched related donor. Eto T, Kobayashi N, Iwato K,
Morishima Y, Sakamaki H, Atsuta
Y, Kanda Y; HLA Working Group;
Donor/Source Working Group; Adult
AML Working Group; Adult ALL
Working Group of the Japan Societyfor Hematopoietic Cell
Transplantation.

2014 4:e263. WGP
17-6

論文タイトル

著者

雑誌名101 Impact of HLA allele mismatch on the Fuji S, Kanda J, Kato S, Ikegame K, Boneclinical outcome in serologicallyMorishima S, Miyamoto T, Hidaka Marrow
matched related hematopoietic SCT. M, Kubo K, Miyamura K, Ohashi K, Transplant
Kobayashi H, Maesako Y, Adachi S,
Ichinohe T, Atsuta Y, Kanda Y;
HLA Working Group of Japan
Society for Hematopoietic Cell
Transplantation.

発行
刊・ 業績番
年
号・頁
号
2014 49(9):11 WGP
87-92. 17-7

102 Impact of HLA mismatch direction on Kanda J, Ichinohe T, Fuji S, Maeda Biol Blood 2015 21(2):30 WGP
the outcome of unrelated bone
Y, Ohashi K, Fukuda T, Miyamura Marrow
5-11.
17-8
marrow transplantation: aK, Iwato K, Eto T, Nakamae H,
Transplant
retrospective analysis from the Japan Kobayashi N, Mori T, Mori S,
Society for Hematopoietic Cell
Morishima Y, Atsuta Y, Kanda Y;
Transplantation.
HLA Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.
103 A single high-resolution HLA
mismatch has a similar adverse
impact on the outcome of related
hematopoietic stem celltransplantation as a single lowresolution HLA mismatch.

Fuji S, Kanda J, Kato S, Ikegame K, Am J
Morishima S, Miyamoto T, Hidaka Hematol
M, Kubo K, Miyamura K, Tsudo M,
Kobayashi H, Maesako Y, Eto T,
Adachi S, Ichinohe T, Atsuta Y,
Kanda Y; HLA Working Group of
the Japan Society for Hematopoietic
Cell Transplantation.

2015 90(7):61 WGP
8-23.
17-9

104 Unrelated bone marrowtransplantation or immediate
umbilical cord blood transplantation
for patients with acute myeloid
leukemia in first complete remission.

Yanada M, Kanda J, Ohtake S,
Eur J
Fukuda T, Sakamaki H, Miyamura Haematol
K, Miyawaki S, Uchida N, Maeda T,
Nagamura-Inoue T, Asou N,
Morishima Y, Atsuta Y, Miyazaki Y,
Kimura F, Kobayashi Y, Takami A,
Naoe T, Kanda Y.

2016 97(3):27 WGP
8-87.
17-10

105 Influence of Differently Licensed
KIR2DL1-Positive Natural Killer
Cells in Transplant Recipients with
Acute Leukemia: A Japanese
National Registry Study.

Arima N, Nakamura F, Yabe T,
Biol Blood 2016 22(3):42 WGP
Tanaka J, Fuji S, Ohashi K, Fukuda Marrow
3-31.
17-11
T, Miyamura K, Iwato K, Eto T,
TransplantMori T, Kobayashi N, Hoshino T,
Kato C, Kanamori H, Nakamae H,
Atsuta Y, Morishima Y, Kanda Y.

106 Haploidentical and Matched Sibling
Donor Hematopoietic Cell
Transplantation for Patients with
HLA-Homozygous Haplotypes.

Kanda J, Ikegame K, Fuji S,
Biol Blood 2016 22(11):2 WGP
Kurokawa M, Kanamori H, Fukuda Marrow
031-7. 17-12
T, Ohashi K, Ishikawa J, Ogawa H, Transplant
Inoue M, Ichinohe T, Atsuta Y,
Kanda Y; HLA Working Group of
the Japan Society for Hematopoietic
Cell Transplantation.

107 Impact of Human Leukocyte Antigen
Allele Mismatch in Unrelated Bone
Marrow Transplantation with
Reduced-Intensity Conditioning
Regimen.

Yokoyama H, Kanda J, Fuji S, Kim Biol Blood 2017 23(2):30 WGP
SW, Fukuda T, Najima Y, Ohno H, Marrow
0-9.
17-13
Uchida N, Ueda Y, Eto T, Iwato K, Transplant
Kobayashi H, Ozawa Y, Kondo T,
Ichinohe T, Atsuta Y, Kanda Y;
HLA Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.

論文タイトル

著者

雑誌名

Bone
108 Impact of the presence of HLA 1-locus Kawamura K, Kanda J, Fuji S,
mismatch and the use of low-dose
Murata M, Ikegame K, Yoshioka K, Marrow
antithymocyte globulin in unrelated Fukuda T, Ozawa Y, Uchida N,
Transplantbone marrow transplantation.
Iwato K, Sakura T, Hidaka M,
Hashimoto H, Ichinohe T, Atsuta Y,
Kanda Y.

発行
刊・ 業績番
年
号・頁
号
2017 52(10):1 WGP
390-8. 17-14

109 Homozygous HLA-C1 is Associatedwith Reduced Risk of Relapse after
HLA-Matched Transplantation in
Patients with Myeloid Leukemia.

Arima N, Kanda J, Tanaka J, Yabe Biol Blood
T, Morishima Y, Kim SW, Najima Y, Marrow
Ozawa Y, Eto T, Kanamori H, Mori Transplant
T, Kobayashi N, Kondo T, Nakamae
H, Uchida N, Inoue M, Fukuda T,
Ichinohe T, Atsuta Y, Kanda Y.

in press WGP
17-15

110 Unrelated cord blood transplantation
vs related transplantation with HLA
1-antigen mismatch in the graftversus-host direction.

Kanda J, Ichinohe T, Kato S,
Uchida N, Terakura S, Fukuda T,
Hidaka M, Ueda Y, Kondo T,
Taniguchi S, Takahashi S,
Nagamura-Inoue T, Tanaka J,
Atsuta Y, Miyamura K, Kanda Y;
Donor/Source Working Group and
HLA Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.

Leukemia

2013 27(2):28 WGP
6-94.
18-1

Kuwatsuka Y, Atsuta Y, Horowitz Biol Blood 2014 20(5):66 WGP
111 Graft-versus-host disease andsurvival after cord blood
MM, Inagaki J, Kanda J, Kato K,
Marrow
2-7.
18-2
transplantation for acute leukemia: a Koh K, Zhang MJ, Eapen M; Center Transplantcomparison of Japanese versus White for International Blood and Marrow
populations.
Transplant Research (CIBMTR),
and Donor/Source and GVHDWorking Group of the Japan Societyfor Hematopoietic Cell
Transplantation (JSHCT).
112 Comparison of cord bloodtransplantation with unrelated bonemarrow transplantation in patientsolder than fifty years.

Tanaka M, Miyamura K, Terakura Biol Blood 2015 21(3):51 WGP
S, Imai K, Uchida N, Ago H, Sakura Marrow
7-25.
18-3
T, Eto T, Ohashi K, Fukuda T,
Transplant
Taniguchi S, Mori S, NagamuraInoue T, Atsuta Y, Okamoto S.

113 Comparison of Outcomes of 8/8 and
7/8 Allele-Matched Unrelated Bone
Marrow Transplantation and SingleUnit Cord Blood Transplantation in
Adults with Acute Leukemia.

Terakura S, Atsuta Y, Tsukada N,
Kobayashi T, Tanaka M, Kanda J,
Najima Y, Fukuda T, Uchida N,
Takahashi S, Nagamura-Inoue T,
Morishima Y, Miyamura K; Japan
Society for Hematopoietic Cell
Transplantation.

114 Comparing Outcomes with Bone
Marrow or Peripheral Blood StemCells as Graft Source for Matched
Sibling Transplants in Severe
Aplastic Anemia across Different
Economic Regions.

Kumar R, Kimura F, Ahn KW, Hu Biol Blood 2016 22(5):93 WGP
ZH, Kuwatsuka Y, Klein JP,
Marrow
2-40.
18-5
Pasquini M, Miyamura K, Kato K, Transplant
Yoshimi A, Inamoto Y, Ichinohe T,
Wood WA Jr, Wirk B, Seftel M,
Rowlings P, Marks DI, Schultz KR,
Gupta V, Dedeken L, George B,
Cahn JY, Szer J, Lee JW, Ho AY,
Fasth A, Hahn T, Khera N, Dalal J,
Bonfim C, Aljurf M, Atsuta Y, Saber
W.

Biol Blood 2016 22(2):33 WGP
Marrow
0-8.
18-4
Transplant

論文タイトル

著者

雑誌名

Biol Blood
115 Graft-versus-Host Disease after HLA- Kanda J, Brazauskas R, Hu ZH,
Matched Sibling Bone Marrow or
Kuwatsuka Y, Nagafuji K,
Marrow
Peripheral Blood Stem Cell
Kanamori H, Kanda Y1, Miyamura Transplant
Transplantation: Comparison ofK, Murata M, Fukuda T, Sakamaki
North American Caucasian andH, Kimura F, Seo S, Aljurf M,
Japanese Populations.
Yoshimi A, Milone G, Wood WA,
Ustun C, Hashimi S, Pasquini M,
Bonfim C, Dalal J, Hahn T, Atsuta
Y, Saber W.
116 Comparison of Donor Sources in
Hematopoietic Stem Cell
Transplantation for Childhood Acute
Leukemia: A Nationwide
Retrospective Study.

発行
刊・ 業績番
年
号・頁
号
2016 22(4):74 WGP
4-51.
18-6

Sakaguchi H, Watanabe N,
Biol Blood 2016 22(12):2 WGP
Matsumoto K, Yabe H, Kato S,
Marrow
226-34. 18-7
Ogawa A, Inagaki J, Goto H, Koh K, Transplant
Yoshida N, Kato K, Cho Y, Kosaka
Y, Takahashi Y, Inoue M, Kato K,
Atsuta Y, Miyamura K;
Donor/Source Working Group ofJapan Society of Hematopoietic Cell
Transplantation.

117 A Comparison of Outcomes for Cord Kuwatsuka Y, Kanda J, Yamazaki
Blood Transplantation and Unrelated H, Mori T, Miyamura K, Kako S,
Bone Marrow Transplantation in
Uchida N, Ohashi K, Ozawa Y,
Adult Aplastic Anemia.
Takahashi Y, Kato C, Iwato K,
Ishiyama K, Kobayashi H, Eto T,
Kahata K, Kato J4, Miyamoto T,
Kato K, Mori S, Atsuta Y, Kimura
F, Kanda Y; Japan Society for
Hematopoietic Cell
Transplantation.

Biol Blood 2016 22(10):1 WGPMarrow
836-43. 18-8
Transplant

118 Comparison of transplant outcomesfrom matched sibling bone marrow or
peripheral blood stem cell andunrelated cord blood in patients 50
years or older.

Konuma T, Tsukada N, Kanda J,
Am J
Uchida N, Ohno Y, Miyakoshi S,
Hematol
Kanamori H, Hidaka M, Sakura T,
Onizuka M, Kobayashi N, Sawa M,
Eto T, Matsuhashi Y, Kato K,
Ichinohe T, Atsuta Y, Miyamura K;
Donor/Source Working Group of theJapan Society for Hematopoietic
Cell Transplantation.

119 Clinical factors predicting the
response of acute graft-versus-hostdisease to corticosteroid therapy: ananalysis from the GVHD Working
Group of the Japan Society for
Hematopoietic Cell Transplantation.

Murata M, Nakasone H, Kanda J, Biol Blood 2013 19(8):11 WGPNakane T, Furukawa T, Fukuda T, Marrow
83-9.
19-1
Mori T, Taniguchi S, Eto T, Ohashi Transplant
K, Hino M, Inoue M, Ogawa H,
Atsuta Y, Nagamura-Inoue T, Yabe
H, Morishima Y, Sakamaki H,
Suzuki R.

120 A case-control study of bronchiolitis
obliterans syndrome following
allogeneic hematopoietic stem celltransplantation.

Nakasone H, Kanda J, Yano S,
Transpl Int 2013 26(6):63 WGP
Atsuta Y, Ago H, Fukuda T,
1-9.
19-2
Kakihana K, Adachi T, Yujiri T,
Taniguchi S, Taguchi J, Morishima
Y, Nagamura T, Sakamaki H, MoriT, Murata M; GVHD Working
Group of the Japan Society for
Hematopoietic Cell
Transplantation.

2016 91(5):E WGP
284-92. 18-9

論文タイトル

著者

雑誌名

発行
刊・ 業績番
年
号・頁
号
2014 49(2):22 WGP
8-35.
19-3

121 Risk factors and organ involvement of Kanda J, Nakasone H, Atsuta Y,
chronic GVHD in Japan.
Toubai T, Yokoyama H, Fukuda T,
Taniguchi S, Ohashi K, Ogawa H,
Eto T, Miyamura K, Morishima Y,
Nagamura-Inoue T, Sakamaki H,
Murata M.

BoneMarrow
Transplant

122 Impact of conditioning intensity and
TBI on acute GVHD after
hematopoietic cell transplantation.

Nakasone H, Fukuda T, Kanda J,
Mori T, Yano S, Kobayashi T,
Miyamura K, Eto T, Kanamori H,
Iwato K, Uchida N, Mori S,
Nagamura-Inoue T, Ichinohe T,
Atsuta Y, Teshima T, Murata M;
GVHD working group of the Japan
Society of Hematopoietic Cell
Transplantation.

Bone
2015 50(4):55 WGP
Marrow
9-65.
19-4
Transplant

123 Age influences post-graft-versus-hostdisease non-relapse mortality inadults with acute graft-versus-hostdisease of varying severity following
allogeneic hematopoietic celltransplant.

Nakane T, Fukuda T, Kanda J,
Taniguchi S, Eto T, Ohashi K,
Nakamae H, Kurokawa M, Mori T,
Morishima Y, Nagamura-Inoue T,
Sakamaki H, Atsuta Y, Murata M.

Leuk2015 56(8):23 WGP
Lymphoma
92-7.
19-5

124 Comparison of continuous and twicedaily infusions of cyclosporine A for
graft-versus-host-disease prophylaxis
in pediatric hematopoietic stem celltransplantation.

Umeda K, Adachi S, Tanaka S,
Pediatr
Ogawa A, Hatakeyama N, Kudo K, Blood
Sakata N, Igarashi S, Ohshima K, Cancer
Hyakuna N, Chin M, Goto H,
Takahashi Y, Azuma E, Koh K,
Sawada A, Kato K, Inoue M, Atsuta
Y, Takami A, Murata M; on behalfof the GVHD Working Group of theJapan Society for Hematopoietic
Cell Transplantation.

2015 62(2):29 WGP
1-8.
19-6

125 A comparison of tacrolimus andcyclosporine combined withmethotrexate for graft-versus-hostdisease prophylaxis, stratified bystem cell source: a retrospective
nationwide survey.

Sakai R, Taguri M, Oshima K, Mori Int J
T, Ago H, Adachi S, Morita S,
Hematol
Taniguchi S, Fukuda T, Ohashi K,
Eto T, Miyamura K, Iwato K,
Kobayashi N, Kanamori H,
Morishima Y, Nagamura-Inoue T,
Sakamaki H, Atsuta Y, Murata M.

2016 103(3):3 WGP
22-33. 19-7

126 Risk factors and prognosis of hepatic
acute GvHD after allogeneic
hematopoietic cell transplantation.

Arai Y, Kanda J, Nakasone H,
Bone2016 51(1):96 WGP
Kondo T, Uchida N, Fukuda T,
Marrow-102.
19-8
Ohashi K, Kaida K, Iwato K, Eto T, Transplant
Kanda Y, Nakamae H, NagamuraInoue T, Morishima Y, Hirokawa M,
Atsuta Y, Murata M.

127 Impact of graft-versus-host disease on Kanda J, Morishima Y, Terakura S, Leukemia
outcomes after unrelated cord blood
Wake A, Uchida N, Takahashi S,transplantation.
Ono Y, Onishi Y, Kanamori H,
Aotsuka N, Ozawa Y, Ogawa H,
Sakura T, Ohashi K, Ichinohe T,
Kato K, Atsuta Y, Teshima T,
Murata M.

2017 31(3):66 WGP
3-8.
19-9

論文タイトル
128 Low-dose thymoglobulin as secondline treatment for steroid-resistantacute GvHD: an analysis of the
JSHCT.

著者

雑誌名

Murata M, Ikegame K, Morishita Y, BoneOgawa H, Kaida K, Nakamae H,
Marrow
Ikeda T, Nishida T, Inoue M, Eto T, Transplant
Kubo K, Sakura T, Mori T, Uchida
N, Ashida T, Matsuhashi Y,
Miyazaki Y, Ichinohe T, Atsuta Y,
Teshima T.

発行
刊・ 業績番
年
号・頁
号
2017 52(2):25 WGP
2-7.
19-10

Terakura S, Wake A, Inamoto Y,
Bone2017 52(3):42 WGP
129 Exploratory research for optimal
GvHD prophylaxis after single unit
Murata M, Sakai R, Yamaguchi T, Marrow
3-30.
19-11
CBT in adults: short-term
Takahashi S, Uchida N, Onishi Y,
Transplant
methotrexate reduced the incidence of Ohashi K, Ozawa Y, Kanamori H,
severe GvHD more than
Yamaguchi H, Fukuda T, Ichinohe
mycophenolate mofetil.
T, Takanashi M, Atsuta Y, Teshima
T.
Inamoto Y, Kimura F, Kanda J,
Haematolo
130 Comparison of graft-versus-hostdisease-free, relapse-free survival
Sugita J, Ikegame K, Nakasone H, gica
according to a variety of graft sources: Nannya Y, Uchida N, Fukuda T,
antithymocyte globulin and single
Yoshioka K, Ozawa Y, Kawano I,
cord blood provide favorable outcomes Atsuta Y, Kato K, Ichinohe T, Inouein some subgroups.
M, Teshima T; JSHCT GVHDWorking Group.

2016 101(12): WGP
159219-12602.

131 Allogeneic unrelated bone marrowtransplantation from older donors
results in worse prognosis inrecipients with aplastic anemia.

Arai Y, Kondo T, Yamazaki H,
Haematolo
Takenaka K, Sugita J, Kobayashi T, gica
Ozawa Y, Uchida N, Iwato K,
Kobayashi N, Takahashi Y,
Ishiyama K, Fukuda T, Ichinohe T,
Atsuta Y, Mori T, Teshima T; Japan
Society for Hematopoietic Cell
Transplantation.

2016 101(5):6 WGP
44-52. 19-13

132 GvHD prophylaxis after single-unit
reduced intensity conditioning cord
blood transplantation in adults withacute leukemia.

Terakura S, Kuwatsuka Y,
Bone2017 52(9):12 WGP
Yamasaki S, Wake A, Kanda J,
Marrow
61-7.
19-14
Inamoto Y, Mizuta S, Yamaguchi T, Transplant
Uchida N, Kouzai Y, Aotsuka N,
Ogawa H, Kanamori H, Nishiwaki
K, Miyakoshi S, Onizuka M, Amano
I, Fukuda T, Ichinohe T, Atsuta Y,
Murata M, Teshima T.

133 Impact of hepatitis C virus infection
on clinical outcome in recipients after
allogeneic hematopoietic celltransplantation.

Nakasone H, Kurosawa S,
Am J
Yakushijin K, Taniguchi S, Murata Hematol
M, Ikegame K, Kobayashi T, Eto T,
Miyamura K, Sakamaki H,
Morishima Y, Nagamura T, Suzuki
R, Fukuda T.

134 Pre-transplant risk factors forcryptogenic organizing
pneumonia/bronchiolitis obliteransorganizing pneumonia after
hematopoietic cell transplantation.

Nakasone H, Onizuka M, Suzuki N, Bone2013 48(10):1 WGP
Fujii N, Taniguchi S, Kakihana K, Marrow
317-23. 20-2
Ogawa H, Miyamura K, Eto T,
Transplant
Sakamaki H, Yabe H, Morishima Y,
Kato K, Suzuki R, Fukuda T.

2013 88(6):47 WGP
7-84.
20-1

Bone
2013 48(9):11 WGP
135 Salvage allogeneic hematopoietic SCT Kato M, Matsumoto K, Suzuki R,
for primary graft failure in children. Yabe H, Inoue M, Kigasawa H,
Marrow
73-8.
20-3
Inagaki J, Koh K, Hashii Y, Tauchi Transplant
H, Suminoe A, Kikuta A, Sakamaki
H, Kawa K, Kato K, Fukuda T.

論文タイトル
136 Impact of pretransplant body massindex on the clinical outcome after
allogeneic hematopoietic SCT.

著者

雑誌名

Fuji S, Takano K, Mori T, Eto T,
BoneTaniguchi S, Ohashi K, Sakamaki Marrow
H, Morishima Y, Kato K, Miyamura Transplant
K, Suzuki R, Fukuda T.

発行
刊・ 業績番
年
号・頁
号
2014 49(12):1 WGP
505-12. 20-4

Takenaka K, Nishida T, Asano-Mori Biol Blood 2015 21(11):2 WGP
137 Cytomegalovirus Reactivation after
Allogeneic Hematopoietic Stem Cell Y, Oshima K, Ohashi K, Mori T,
Marrow008-16. 20-5
Transplantation is Associated with a Kanamori H, Miyamura K, Kato C, Transplant
Reduced Risk of Relapse in Patients Kobayashi N, Uchida N, Nakamaewith Acute Myeloid Leukemia Who
H, Ichinohe T, Morishima Y, Suzuki
Survived to Day 100 after
R, Yamaguchi T, Fukuda T.
Transplantation: The Japan Societyfor Hematopoietic Cell
Transplantation Transplantationrelated Complication Working Group.
138 Pre-transplant diabetes mellitus is arisk factor for non-relapse mortality,
especially infection-related mortality,
after allogeneic hematopoietic SCT.

Takano K, Fuji S, Uchida N, Ogawa Bone2015 50(4):55 WGP
H, Ohashi K, Eto T, Sakamaki H,
Marrow
3-8.
20-6
Morishima Y, Kato K, Suzuki R,
Transplant
Fukuda T.

139 Sinusoidal obstruction syndrome
after allogeneic hematopoietic stem
cell transplantation: Incidence, risk
factors and outcomes.

Yakushijin K, Atsuta Y, Doki N,
Yokota A, Kanamori H, Miyamoto
T, Ohwada C, Miyamura K, Nawa
Y, Kurokawa M, Mizuno I, Mori T,
Onizuka M, Taguchi J, Ichinohe T,
Yabe H, Morishima Y, Kato K,
Suzuki R, Fukuda T.

140 Donor cell-derived hematologic
malignancy: A survey by the Japansociety for hematopoietic celltransplantation.

Kato M, Yamashita T, Suzuki R,
Leukemia
Matsumoto K, Nishimori H,
Takahashi S, Iwato K, Nakaseko C,
Kondo T, Imada K, Kimura F,
Ichinohe T, Hashii Y, Kato K,
Atsuta Y, Taniguchi S, Fukuda T.

2016 30(8):17 WGP
42-5.
20-8

141 Impact of total body irradiation on
successful neutrophil engraftment in
unrelated bone marrow or cord bloodtransplantation.

Nakasone H, Fuji S, Yakushijin K, Am J
Onizuka M, Shinohara A, Ohashi K, Hematol
Miyamura K, Uchida N, Takanashi
M, Ichinohe T, Atsuta Y, Fukuda T,
Ogata M; Complication Working
Group of Japanese Society for
Hematopoietic Cell
Transplantation.

2017 92(2):17 WGP
1-8.
20-9

142 Clinical characteristics and outcomeof human herpesvirus-6 encephalitis
after allogeneic hematopoietic stem
cell transplantation.

Ogata M, Oshima K, Ikebe T,
Bone2017 52(11):1 WGP
Takano K, Kanamori H, Kondo T,
Marrow
563-70. 20-10
Ueda Y, Mori T, Hashimoto H,
Transplant.
Ogawa H, Eto T, Ueki T, Miyamoto
T, Ichinohe T, Atsuta Y, Fukuda T.

Bone2016 51(3):40 WGP
Marrow
3-9.
20-7
Transplant

論文タイトル著者

雑誌名

143 Late Mortality and Causes of Death Atsuta Y, Hirakawa A, Nakasone H, Biol Bloodamong Long-Term Survivors after
Kurosawa S, Oshima K, Sakai R,
Marrow
Allogeneic Stem Cell Transplantation. Ohashi K, Takahashi S, Mori T,
TransplantOzawa Y, Fukuda T, Kanamori H,
Morishima Y, Kato K, Yabe H,
Sakamaki H, Taniguchi S,
Yamashita T; Late Effect andQuality of Life Working Group of
the Japan Society for Hematopoietic
Cell Transplantation.

発行
刊・ 業績番
年
号・頁
号
2016 22(9):17 WGP
02-9.
21-1